SCHEMBL15823923

SCHEMBL15823923

NCCc1ccc(OCCCc2ccc(-c3ccccc3)c(NC(=O)O)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.47
PPARG P37231 2/20 0.45
S1PR1 P21453 3/20 0.45
S1PR3 Q99500 2/20 0.45
ITGB3 P05106 2/20 0.44
ITGA2B P08514 2/20 0.44
BACE1 P56817 1/20 0.43
S1PR4 O95977 1/20 0.43
S1PR5 Q9H228 1/20 0.43
LTA4H P09960 1/20 0.42
NPC1 O15118 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15822991 0.97 FFAR1 (0.48) FFAR1PPARGS1PR1S1PR3ITGB3
SCHEMBL15822453 0.91 SIRT2 (0.45) FFAR1PPARGBACE1MAOAMAOB
SCHEMBL15822497 0.83 BACE1 (0.44) BACE1MAOA
SCHEMBL100205 0.81 PDK2 (0.44) PPARGS1PR1S1PR3ITGB3ITGA2B
SCHEMBL15824362 0.79 LMNA (0.45) S1PR1MAPT
SCHEMBL15822461 0.77 PPARA (0.41) FFAR1PPARGS1PR1S1PR3ITGB3
SCHEMBL15822464 0.77 PPARA (0.41) FFAR1PPARGS1PR1S1PR3ITGB3
SCHEMBL15824687 0.75 KMT2A (0.46) NPC1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL15823506 0.75 PNLIP (0.46) NPC1CYP1A2CYP3A4MAPTCYP2C9
SCHEMBL13886620 0.75 HTR2A (0.68) FFAR1S1PR1S1PR3LTA4HNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2934594-B1 CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES . ALMIRALL SA (ES) 2019-09-04 EP disclosed
EP-2934594-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY Almirall, S.A. (ES) 2015-10-28 EP disclosed
WO-2014095920-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY ALMIRALL, S.A. (ES) 2014-06-26 WO disclosed